{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:42:22Z","timestamp":1794555742315,"version":"4.9.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["N_CUHK448\/24"],"award-info":[{"award-number":["N_CUHK448\/24"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14109025"],"award-info":[{"award-number":["14109025"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["GJHZ2022091 314420901"],"award-info":[{"award-number":["GJHZ2022091 314420901"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41391-025-01042-y","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:51:24Z","timestamp":1760809884000},"page":"478-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuroscience in prostate cancer"],"prefix":"10.1038","volume":"29","author":[{"given":"Ziteng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1499-8372","authenticated-orcid":false,"given":"Peter Ka-Fung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9361-2342","authenticated-orcid":false,"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-9626","authenticated-orcid":false,"given":"Dinglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1723-9646","authenticated-orcid":false,"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"1042_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618:467\u201379.","journal-title":"Nature"},{"key":"1042_CR2","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, et al. Cancer neuroscience: State of the field, emerging directions. Cell. 2023;186:1689\u2013707.","journal-title":"Cell"},{"key":"1042_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","volume":"25","author":"M Amit","year":"2025","unstructured":"Amit M, Eichwald T, Roger A, Anderson J, Chang A, Vermeer PD, et al. Neuro-immune cross-talk in cancer. Nat Rev Cancer. 2025;25:573\u201389.","journal-title":"Nat Rev Cancer"},{"key":"1042_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","volume":"23","author":"D Yaniv","year":"2024","unstructured":"Yaniv D, Mattson B, Talbot S, Gleber-Netto FO, Amit M. Targeting the peripheral neural-tumour microenvironment for cancer therapy. Nat Rev Drug Discov. 2024;23:780\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"1042_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41:573\u201380.","journal-title":"Cancer Cell"},{"key":"1042_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","volume":"644","author":"G Hoover","year":"2025","unstructured":"Hoover G, Gilbert S, Curley O, Obellianne C, Lin MT, Hixson W, et al. Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature. 2025;644:252\u201362.","journal-title":"Nature"},{"key":"1042_CR7","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-23-1754","volume":"83","author":"Y Ye","year":"2023","unstructured":"Ye Y, Xie T, Amit M. Targeting the nerve-cancer circuit. Cancer Res. 2023;83:2445\u20137.","journal-title":"Cancer Res"},{"key":"1042_CR8","doi-asserted-by":"publisher","first-page":"eade4443","DOI":"10.1126\/sciadv.ade4443","volume":"9","author":"AC Restaino","year":"2023","unstructured":"Restaino AC, Walz A, Vermeer SJ, Barr J, Kov\u00e1cs A, Fettig RR, et al. Functional neuronal circuits promote disease progression in cancer. Sci Adv. 2023;9:eade4443.","journal-title":"Sci Adv"},{"key":"1042_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-025-02144-4","volume":"26","author":"C Zheng","year":"2025","unstructured":"Zheng C, Liu S, Fazel Modares N, St Paul M, Mak TW. Cholinergic T cells revitalize the tumor immune microenvironment: TIME to ChAT. Nat Immunol. 2025;26:665\u201377.","journal-title":"Nat Immunol"},{"key":"1042_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399.","journal-title":"Nat Rev Immunol"},{"key":"1042_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, Zhao S, Roginsky J, Maltez VI, Guiza J, Avina-Ochoa N, et al. The \u03b2(1)-adrenergic receptor links sympathetic nerves to T\u2009cell exhaustion. Nature. 2023;622:383\u201392.","journal-title":"Nature"},{"key":"1042_CR12","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1158\/0008-5472.CAN-17-0108","volume":"77","author":"R Udumyan","year":"2017","unstructured":"Udumyan R, Montgomery S, Fang F, Almroth H, Valdimarsdottir U, Ekbom A, et al. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res. 2017;77:3700\u20137.","journal-title":"Cancer Res"},{"key":"1042_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejca.2022.01.017","volume":"165","author":"OJ Kennedy","year":"2022","unstructured":"Kennedy OJ, Kicinski M, Valpione S, Gandini S, Suciu S, Blank CU, et al. Prognostic and predictive value of \u03b2-blockers in the EORTC 1325\/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. Eur J Cancer. 2022;165:97\u2013112.","journal-title":"Eur J Cancer"},{"key":"1042_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, Ostendorf BN, Kerner Z, Tavazoie SF. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature. 2024;633:207\u201315.","journal-title":"Nature"},{"key":"1042_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41586-025-08591-1","volume":"640","author":"X Zhi","year":"2025","unstructured":"Zhi X, Wu F, Qian J, Ochiai Y, Lian G, Malagola E, et al. Nociceptive neurons promote gastric tumour progression via a CGRP-RAMP1 axis. Nature. 2025;640:802\u201310.","journal-title":"Nature"},{"key":"1042_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1590\/S0041-87812002000600008","volume":"57","author":"AO Rodrigues","year":"2002","unstructured":"Rodrigues AO, Machado MT, Wroclawski ER. Prostate innervation and local anesthesia in prostate procedures. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:287\u201392.","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"1042_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/(SICI)1097-0045(1998)8+<2::AID-PROS2>3.0.CO;2-U","volume":"8","author":"KT McVary","year":"1998","unstructured":"McVary KT, McKenna KE, Lee C. Prostate innervation. Prostate Suppl. 1998;8:2\u201313.","journal-title":"Prostate Suppl"},{"key":"1042_CR18","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.juro.2016.10.105","volume":"197","author":"PC Walsh","year":"2017","unstructured":"Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 2017;197:S165\u2013s70.","journal-title":"J Urol"},{"key":"1042_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0022-5347(17)50344-4","volume":"131","author":"TF Lue","year":"1984","unstructured":"Lue TF, Zeineh SJ, Schmidt RA, Tanagho EA. Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol. 1984;131:273\u201380.","journal-title":"J Urol"},{"key":"1042_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ju.0000168033.81966.aa","volume":"174","author":"PC Walsh","year":"2005","unstructured":"Walsh PC. Anatomical studies of the neurovascular bundle and cavernosal nerves. J Urol. 2005;174:566.","journal-title":"J Urol"},{"key":"1042_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0022-5347(17)40789-0","volume":"141","author":"J Breza","year":"1989","unstructured":"Breza J, Aboseif SR, Orvis BR, Lue TF, Tanagho EA. Detailed anatomy of penile neurovascular structures: surgical significance. J Urol. 1989;141:437\u201343.","journal-title":"J Urol"},{"key":"1042_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.eururo.2016.01.026","volume":"70","author":"J Walz","year":"2016","unstructured":"Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J, et al. A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol. 2016;70:301\u201311.","journal-title":"Eur Urol"},{"key":"1042_CR23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol. 2006;50:969\u201379.","journal-title":"Eur Urol"},{"key":"1042_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11930-019-00210-1","volume":"11","author":"JY Leong","year":"2019","unstructured":"Leong JY, Patel AS, Ramasamy R. Minimizing sexual dysfunction in BPH surgery. Curr Sex Health Rep. 2019;11:190\u2013200.","journal-title":"Curr Sex Health Rep"},{"key":"1042_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1464-410X.1994.tb07612.x","volume":"73","author":"JM Gil-Vernet Jr","year":"1994","unstructured":"Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, Gil-Vernet JM. Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol. 1994;73:442\u20138.","journal-title":"Br J Urol"},{"key":"1042_CR26","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1242\/dev.148270","volume":"144","author":"R Toivanen","year":"2017","unstructured":"Toivanen R, Shen MM. Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development. 2017;144:1382\u201398.","journal-title":"Development"},{"key":"1042_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1006\/exnr.1999.7127","volume":"158","author":"JP Golden","year":"1999","unstructured":"Golden JP, DeMaro JA, Osborne PA, Milbrandt J, Johnson EM Jr. Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol. 1999;158:504\u201328.","journal-title":"Exp Neurol"},{"key":"1042_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/S0092-8674(00)81311-2","volume":"85","author":"S Jing","year":"1996","unstructured":"Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996;85:1113\u201324.","journal-title":"Cell"},{"key":"1042_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.12954\/PI.13020","volume":"1","author":"YH Park","year":"2013","unstructured":"Park YH, Jeong CW, Lee SE. A comprehensive review of neuroanatomy of the prostate. Prostate Int. 2013;1:139\u201345.","journal-title":"Prostate Int"},{"key":"1042_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/BF00344342","volume":"66","author":"C Owman","year":"1965","unstructured":"Owman C, Sjoestrand NO. Short adrenergic neurons and catecholamine-containing cells in vas deferens and accessory male genital glands of different mammals. Z Zellforsch Mikros Anat. 1965;66:300\u201320.","journal-title":"Z Zellforsch Mikros Anat"},{"key":"1042_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00755-6","volume":"19","author":"M Archer","year":"2021","unstructured":"Archer M, Dogra N, Dovey Z, Ganta T, Jang HS, Khusid JA, et al. Role of \u03b1- and \u03b2-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease. Cell Commun Signal. 2021;19:78.","journal-title":"Cell Commun Signal"},{"key":"1042_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0163-7258(02)00174-2","volume":"94","author":"S Ventura","year":"2002","unstructured":"Ventura S, Pennefather J, Mitchelson F. Cholinergic innervation and function in the prostate gland. Pharmacol Ther. 2002;94:93\u2013112.","journal-title":"Pharmacol Ther"},{"key":"1042_CR33","doi-asserted-by":"crossref","unstructured":"Sasaki T, Franco OE, Hayward SW. Prostate - Overview. In Skinner MK, editor. Encyclopedia of Reproduction, 2nd edition. Academic Press; 2018. vol. 1, p. 309-314.","DOI":"10.1016\/B978-0-12-801238-3.64595-6"},{"key":"1042_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1497735","volume":"17","author":"H Xia","year":"2024","unstructured":"Xia H, Jerde TJ, Fehrenbacher JC. Sensory innervation in the prostate and a role for calcitonin gene-related peptide in prostatic epithelial proliferation. Front Mol Neurosci. 2024;17:1497735.","journal-title":"Front Mol Neurosci"},{"key":"1042_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.eururo.2015.10.053","volume":"69","author":"D Iglesias-Gato","year":"2016","unstructured":"Iglesias-Gato D, Wikstr\u00f6m P, Tyanova S, Lavallee C, Thysell E, Carlsson J, et al. The proteome of primary prostate cancer. Eur Urol. 2016;69:942\u201352.","journal-title":"Eur Urol"},{"key":"1042_CR36","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.coph.2024.102476","volume":"78","author":"I Matak","year":"2024","unstructured":"Matak I, Lackovi\u0107 Z. Native botulinum toxin type A vs. redesigned botulinum toxins in pain: what did we learn so far?. Curr Opin Pharm. 2024;78:102476.","journal-title":"Curr Opin Pharm"},{"key":"1042_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrurol.2015.169","volume":"12","author":"G Magistro","year":"2015","unstructured":"Magistro G, Stief CG, Gratzke C. New intraprostatic injectables and prostatic urethral lift for male LUTS. Nat Rev Urol. 2015;12:461\u201371.","journal-title":"Nat Rev Urol"},{"key":"1042_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.eururo.2012.10.005","volume":"63","author":"M Marberger","year":"2013","unstructured":"Marberger M, Chartier-Kastler E, Egerdie B, Lee KS, Grosse J, Bugarin D, et al. A randomized double-blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia. Eur Urol. 2013;63:496\u2013503.","journal-title":"Eur Urol"},{"key":"1042_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.juro.2014.02.004","volume":"192","author":"KT McVary","year":"2014","unstructured":"McVary KT, Roehrborn CG, Chartier-Kastler E, Efros M, Bugarin D, Chen R, et al. A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol. 2014;192:150\u20136.","journal-title":"J Urol"},{"key":"1042_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2008.01.088","volume":"56","author":"R Bartoletti","year":"2009","unstructured":"Bartoletti R, Gavazzi A, Cai T, Mondaini N, Morelli A, Del Popolo G, et al. Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. Eur Urol. 2009;56:142\u20138.","journal-title":"Eur Urol"},{"key":"1042_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.sc.3101804","volume":"44","author":"JH Frisbie","year":"2006","unstructured":"Frisbie JH, Kumar S, Aguilera EJ, Yalla S. Prostate atrophy and spinal cord lesions. Spinal Cord. 2006;44:24\u20137.","journal-title":"Spinal Cord"},{"key":"1042_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bju.12027","volume":"112","author":"J Pannek","year":"2013","unstructured":"Pannek J, Bartel P, G\u00f6cking K, Frotzler A. Prostate volume in male patients with spinal cord injury: a question of nerves?. BJU Int. 2013;112:495\u2013500.","journal-title":"BJU Int"},{"key":"1042_CR43","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.trecan.2017.10.001","volume":"3","author":"A Rutledge","year":"2017","unstructured":"Rutledge A, Jobling P, Walker MM, Denham JW, Hondermarck H. Spinal cord injuries and nerve dependence in prostate cancer. Trends Cancer. 2017;3:812\u20135.","journal-title":"Trends Cancer"},{"key":"1042_CR44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0022-5347(17)38881-X","volume":"142","author":"A Villers","year":"1989","unstructured":"Villers A, McNeal JE, Redwine EA, Freiha FS, Stamey TA. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol. 1989;142:763\u20138.","journal-title":"J Urol"},{"key":"1042_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00000478-198004000-00006","volume":"4","author":"MO Hassan","year":"1980","unstructured":"Hassan MO, Maksem J. The prostatic perineural space and its relation to tumor spread: an ultrastructural study. Am J Surg Pathol. 1980;4:143\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1042_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/pros.1137","volume":"49","author":"GE Ayala","year":"2001","unstructured":"Ayala GE, Wheeler TM, Shine HD, Schmelz M, Frolov A, Chakraborty S, et al. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate. 2001;49:213\u201323.","journal-title":"Prostate"},{"key":"1042_CR47","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","volume":"14","author":"GE Ayala","year":"2008","unstructured":"Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, et al. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008;14:7593\u2013603.","journal-title":"Clin Cancer Res"},{"key":"1042_CR48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/ijc.29046","volume":"136","author":"K Dobrenis","year":"2015","unstructured":"Dobrenis K, Gauthier LR, Barroca V, Magnon C. Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development. Int J Cancer. 2015;136:982\u20138.","journal-title":"Int J Cancer"},{"key":"1042_CR49","doi-asserted-by":"publisher","first-page":"e13751","DOI":"10.1371\/journal.pone.0013751","volume":"5","author":"DA Barron","year":"2010","unstructured":"Barron DA, Strand DW, Ressler SJ, Dang TD, Hayward SW, Yang F, et al. TGF-\u03b21 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse. PLoS One. 2010;5:e13751.","journal-title":"PLoS One"},{"key":"1042_CR50","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361.","journal-title":"Science"},{"key":"1042_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, Arnal-Estap\u00e9 A, Maryanovich M, Nakahara F, Cruz CD, Finley LWS, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358:321\u20136.","journal-title":"Science"},{"key":"1042_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41585-019-0274-3","volume":"17","author":"B March","year":"2020","unstructured":"March B, Faulkner S, Jobling P, Steigler A, Blatt A, Denham J, et al. Tumour innervation and neurosignalling in prostate cancer. Nat Rev Urol. 2020;17:119\u201330.","journal-title":"Nat Rev Urol"},{"key":"1042_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.eururo.2013.04.043","volume":"65","author":"J Br\u00fcndl","year":"2014","unstructured":"Br\u00fcndl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R. Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci. Eur Urol. 2014;65:802\u20138.","journal-title":"Eur Urol"},{"key":"1042_CR54","doi-asserted-by":"publisher","first-page":"eaax6040","DOI":"10.1126\/sciadv.aax6040","volume":"6","author":"H You","year":"2020","unstructured":"You H, Shang W, Min X, Weinreb J, Li Q, Leapman M, et al. Sight and switch off: Nerve density visualization for interventions targeting nerves in prostate cancer. Sci Adv. 2020;6:eaax6040.","journal-title":"Sci Adv"},{"key":"1042_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pros.23454","volume":"78","author":"C Coarfa","year":"2018","unstructured":"Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, et al. Influence of the neural microenvironment on prostate cancer. Prostate. 2018;78:128\u201339.","journal-title":"Prostate"},{"key":"1042_CR56","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/pros.20958","volume":"69","author":"G Karsenty","year":"2009","unstructured":"Karsenty G, Rocha J, Chevalier S, Scarlata E, Andrieu C, Zouanat FZ, et al. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo. Prostate. 2009;69:1143\u201350.","journal-title":"Prostate"},{"key":"1042_CR57","first-page":"1967","volume":"18","author":"RI Shebl","year":"2019","unstructured":"Shebl RI. Anti-cancer potential of captopril and botulinum toxin type-A and associated p53 gene apototic stimulating activity. Iran J Pharm Res. 2019;18:1967\u201377.","journal-title":"Iran J Pharm Res"},{"key":"1042_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710899","volume":"11","author":"D Sigorski","year":"2021","unstructured":"Sigorski D, Gulczy\u0144ski J, Sejda A, Rogowski W, I\u017cycka-\u015awieszewska E. Investigation of neural microenvironment in prostate cancer in context of neural density, perineural invasion, and neuroendocrine profile of tumors. Front Oncol. 2021;11:710899.","journal-title":"Front Oncol"},{"key":"1042_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pros.24081","volume":"81","author":"Y Ding","year":"2021","unstructured":"Ding Y, Lee M, Gao Y, Bu P, Coarfa C, Miles B, et al. Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance. Prostate. 2021;81:58\u201371.","journal-title":"Prostate"},{"key":"1042_CR60","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13578-023-01008-4","volume":"13","author":"M Di Donato","year":"2023","unstructured":"Di Donato M, Giovannelli P, Migliaccio A, Castoria G. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue. Cell Biosci. 2023;13:60.","journal-title":"Cell Biosci"},{"key":"1042_CR61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4149\/neo_2023_231116N593","volume":"70","author":"F Blasko","year":"2023","unstructured":"Blasko F, Krivosikova L, Babal P, Breza J, Trebaticky B, Kuruc R, et al. Innervation density and types of nerves in prostate cancer. Neoplasma. 2023;70:787\u201395.","journal-title":"Neoplasma"},{"key":"1042_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113691","volume":"155","author":"Q Liu","year":"2022","unstructured":"Liu Q, Ma Z, Cao Q, Zhao H, Guo Y, Liu T, et al. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691.","journal-title":"Biomed Pharmacother"},{"key":"1042_CR63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/JU.0000000000002963","volume":"209","author":"CM de la Calle","year":"2023","unstructured":"de la Calle CM, Mamawala MM, Landis P, Macura KJ, Trock BJ, Epstein JI, et al. Clinical significance of perineural invasion in men with grade group 1 prostate cancer on active surveillance. J Urol. 2023;209:180\u20136.","journal-title":"J Urol"},{"key":"1042_CR64","doi-asserted-by":"crossref","unstructured":"Siech C, Wenzel M, Grosshans N, Cano Garcia C, Humke C, Koll FJ, et al. The association between lymphovascular or perineural invasion in radical prostatectomy specimen and biochemical recurrence. Cancers. 2024;16:3648.","DOI":"10.3390\/cancers16213648"},{"key":"1042_CR65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00428-024-03779-8","volume":"486","author":"BG Gertsen","year":"2025","unstructured":"Gertsen BG, Teramoto Y, Wang Y, Tsuzuki T, Miyamoto H. Clinical significance of location of perineural cancer invasion detected on prostate needle core biopsy. Virchows Arch. 2025;486:411\u20135.","journal-title":"Virchows Arch"},{"key":"1042_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02983-x","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Ma Z, Zhang Y, Feng H, Li Y, Sang W, et al. Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion. Cancer Cell Int. 2023;23:141.","journal-title":"Cancer Cell Int"},{"key":"1042_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1073232","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Wang S, Fu Z, Gao Q, Yang L, Lei Z, et al. Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion. Front Genet. 2022;13:1073232.","journal-title":"Front Genet"},{"key":"1042_CR68","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.eururo.2007.12.007","volume":"54","author":"LP Witte","year":"2008","unstructured":"Witte LP, Chapple CR, de la Rosette JJ, Michel MC. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol. 2008;54:326\u201334.","journal-title":"Eur Urol"},{"key":"1042_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fonc.2015.00037","volume":"5","author":"AD Grigore","year":"2015","unstructured":"Grigore AD, Ben-Jacob E, Farach-Carson MC. Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?. Front Oncol. 2015;5:37.","journal-title":"Front Oncol"},{"key":"1042_CR70","first-page":"128","volume":"29","author":"J Huang","year":"2007","unstructured":"Huang J, Wu C, di Sant\u2019Agnese PA, Yao JL, Cheng L, Na Y. Function and molecular mechanisms of neuroendocrine cells in prostate cancer. Anal Quant Cytol Histol. 2007;29:128\u201338.","journal-title":"Anal Quant Cytol Histol"},{"key":"1042_CR71","doi-asserted-by":"publisher","first-page":"1012005","DOI":"10.3389\/fendo.2022.1012005","volume":"13","author":"T Arman","year":"2022","unstructured":"Arman T, Nelson PS. Endocrine and paracrine characteristics of neuroendocrine prostate cancer. Front Endocrinol (Lausanne). 2022;13:1012005.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1042_CR72","doi-asserted-by":"publisher","first-page":"111097","DOI":"10.1016\/j.celrep.2022.111097","volume":"40","author":"R Islam","year":"2022","unstructured":"Islam R, Mishra J, Polavaram NS, Bhattacharya S, Hong Z, Bodas S, et al. Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance. Cell Rep. 2022;40:111097.","journal-title":"Cell Rep"},{"key":"1042_CR73","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41583-023-00677-x","volume":"24","author":"MR Ananth","year":"2023","unstructured":"Ananth MR, Rajebhosale P, Kim R, Talmage DA, Role LW. Basal forebrain cholinergic signalling: development, connectivity and roles in cognition. Nat Rev Neurosci. 2023;24:233\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"1042_CR74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183544","volume":"135","author":"K Liu","year":"2025","unstructured":"Liu K, Zhang Y, Du G, Chen X, Xiao L, Jiang L, et al. 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. J Clin Invest. 2025;135:e183544.","journal-title":"J Clin Invest"},{"key":"1042_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s42003-020-01549-1","volume":"4","author":"WY Chen","year":"2021","unstructured":"Chen WY, Wen YC, Lin SR, Yeh HL, Jiang KC, Chen WH, et al. Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance. Commun Biol. 2021;4:22.","journal-title":"Commun Biol"},{"key":"1042_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05836-7","volume":"14","author":"YC Wen","year":"2023","unstructured":"Wen YC, Tram VTN, Chen WH, Li CH, Yeh HL, Thuy Dung PV, et al. CHRM4\/AKT\/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis. 2023;14:304.","journal-title":"Cell Death Dis"},{"key":"1042_CR77","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1158\/1541-7786.MCR-18-0605","volume":"17","author":"PR Braadland","year":"2019","unstructured":"Braadland PR, Ramberg H, Grytli HH, Urbanucci A, Nielsen HK, Guldvik IJ, et al. The \u03b2(2)-adrenergic receptor is a molecular switch for neuroendocrine transdifferentiation of prostate cancer cells. Mol Cancer Res. 2019;17:2154\u201368.","journal-title":"Mol Cancer Res"},{"key":"1042_CR78","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nature05300","volume":"444","author":"NC Spitzer","year":"2006","unstructured":"Spitzer NC. Electrical activity in early neuronal development. Nature. 2006;444:707\u201312.","journal-title":"Nature"},{"key":"1042_CR79","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0896-6273(01)00217-3","volume":"29","author":"G Ming","year":"2001","unstructured":"Ming G, Henley J, Tessier-Lavigne M, Song H, Poo M. Electrical activity modulates growth cone guidance by diffusible factors. Neuron. 2001;29:441\u201352.","journal-title":"Neuron"},{"key":"1042_CR80","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41586-024-08575-7","volume":"639","author":"P Peinado","year":"2025","unstructured":"Peinado P, Stazi M, Ballabio C, Margineanu MB, Li Z, Col\u00f3n CI, et al. Intrinsic electrical activity drives small-cell lung cancer progression. Nature. 2025;639:765\u201375.","journal-title":"Nature"},{"key":"1042_CR81","doi-asserted-by":"crossref","unstructured":"Bery F, Cancel M, Chant\u00f4me A, Guibon R, Bruy\u00e8re F, Rozet F, et al. The calcium-sensing receptor is a marker and potential driver of neuroendocrine differentiation in prostate cancer. Cancers. 2020;12:860.","DOI":"10.3390\/cancers12040860"},{"key":"1042_CR82","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.autrev.2007.03.004","volume":"7","author":"G Di Comite","year":"2007","unstructured":"Di Comite G, Grazia Sabbadini M, Corti A, Rovere-Querini P, Manfredi AA. Conversation galante: how the immune and the neuroendocrine systems talk to each other. Autoimmun Rev. 2007;7:23\u20139.","journal-title":"Autoimmun Rev"},{"key":"1042_CR83","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.adh5483","volume":"384","author":"LF Seeholzer","year":"2024","unstructured":"Seeholzer LF, Julius D. Neuroendocrine cells initiate protective upper airway reflexes. Science. 2024;384:295\u2013301.","journal-title":"Science"},{"key":"1042_CR84","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/pros.24705","volume":"84","author":"KI Uemura","year":"2024","unstructured":"Uemura KI, Togo A, Hiroshige T, Ohta K, Ueda K, Nishihara K, et al. Three-dimensional ultrastructural and anatomical analysis of prostatic neuroendocrine cells in mice. Prostate. 2024;84:866\u201376.","journal-title":"Prostate"},{"key":"1042_CR85","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1158\/0008-5472.CAN-16-0899","volume":"77","author":"S Sinha","year":"2017","unstructured":"Sinha S, Fu YY, Grimont A, Ketcham M, Lafaro K, Saglimbeni JA, et al. PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk. Cancer Res. 2017;77:1868\u201379.","journal-title":"Cancer Res"},{"key":"1042_CR86","doi-asserted-by":"crossref","unstructured":"Savchuk S, Gentry K, Wang W, Carleton E, Yal\u00e7\u0131n B, Liu Y, et al. Neuronal-activity dependent mechanisms of small cell lung cancer progression. bioRxiv. 2023. http:\/\/www.biorxiv.org\/content\/10.1101\/2023.01.19.524430v1.","DOI":"10.1101\/2023.01.19.524430"},{"key":"1042_CR87","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41420-021-00752-1","volume":"7","author":"S Dwivedi","year":"2021","unstructured":"Dwivedi S, Bautista M, Shrestha S, Elhasasna H, Chaphekar T, Vizeacoumar FS, et al. Sympathetic signaling facilitates progression of neuroendocrine prostate cancer. Cell Death Discov. 2021;7:364.","journal-title":"Cell Death Discov"},{"key":"1042_CR88","first-page":"375","volume":"4","author":"PR Braadland","year":"2014","unstructured":"Braadland PR, Ramberg H, Grytli HH, Task\u00e9n KA. \u03b2-adrenergic receptor signaling in prostate cancer. Front Oncol. 2014;4:375.","journal-title":"Front Oncol"},{"key":"1042_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58118-z","volume":"10","author":"L Yin","year":"2020","unstructured":"Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, et al. Cancer cell\u2019s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction. Sci Rep. 2020;10:1216.","journal-title":"Sci Rep"},{"key":"1042_CR90","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1016\/j.neuron.2023.10.004","volume":"111","author":"C Magnon","year":"2023","unstructured":"Magnon C. Claire Magnon. Neuron. 2023;111:3358\u201360.","journal-title":"Neuron"},{"key":"1042_CR91","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.ejca.2014.08.006","volume":"50","author":"J Assayag","year":"2014","unstructured":"Assayag J, Pollak MN, Azoulay L. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer. Eur J Cancer. 2014;50:2838\u201345.","journal-title":"Eur J Cancer"},{"key":"1042_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06644-7","volume":"23","author":"MH Thulin","year":"2025","unstructured":"Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, et al. Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis. J Transl Med. 2025;23:672.","journal-title":"J Transl Med"},{"key":"1042_CR93","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/j.ymthe.2024.08.028","volume":"32","author":"I Ajmal","year":"2024","unstructured":"Ajmal I, Farooq MA, Duan Y, Yao J, Gao Y, Hui X, et al. Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer. Mol Ther. 2024;32:3539\u201357.","journal-title":"Mol Ther"},{"key":"1042_CR94","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/0284186X.2022.2101902","volume":"61","author":"R Udumyan","year":"2022","unstructured":"Udumyan R, Botteri E, Jerlstrom T, Montgomery S, Smedby KE, Fall K. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study. Acta Oncol. 2022;61:922\u201330.","journal-title":"Acta Oncol"},{"key":"1042_CR95","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3892\/or.2016.4918","volume":"36","author":"WJ Wei","year":"2016","unstructured":"Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY. Propranolol sensitizes thyroid cancer cells to cytotoxic effect of vemurafenib. Oncol Rep. 2016;36:1576\u201384.","journal-title":"Oncol Rep"},{"key":"1042_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87525-z","volume":"11","author":"LE Anselmino","year":"2021","unstructured":"Anselmino LE, Baglioni MV, Malizia F, Laluce NC, Etichetti CB, Marignac VLM, et al. Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment. Sci Rep. 2021;11:8091.","journal-title":"Sci Rep"},{"key":"1042_CR97","doi-asserted-by":"crossref","unstructured":"Sidorova M, Petrikait\u0117 V. The effect of beta adrenoreceptor blockers on viability and cell colony formation of non-small cell lung cancer cell lines A549 and H1299. Molecules. 2022;27:1938.","DOI":"10.3390\/molecules27061938"},{"key":"1042_CR98","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s10238-022-00842-z","volume":"23","author":"H Chang","year":"2023","unstructured":"Chang H, Lee SH. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis. Clin Exp Med. 2023;23:853\u20138.","journal-title":"Clin Exp Med"},{"key":"1042_CR99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10585-023-10258-y","volume":"41","author":"SG Nair","year":"2024","unstructured":"Nair SG, Benny S, Jose WM, Aneesh TP. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation. Clin Exp Metastasis. 2024;41:9\u201324.","journal-title":"Clin Exp Metastasis"},{"key":"1042_CR100","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00204-022-03271-9","volume":"96","author":"M Pirazzini","year":"2022","unstructured":"Pirazzini M, Montecucco C, Rossetto O. Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Arch Toxicol. 2022;96:1521\u201339.","journal-title":"Arch Toxicol"},{"key":"1042_CR101","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1124\/pr.116.012658","volume":"69","author":"M Pirazzini","year":"2017","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology. Pharmacol Rev. 2017;69:200\u201335.","journal-title":"Pharmacol Rev"},{"key":"1042_CR102","doi-asserted-by":"crossref","unstructured":"Giuliano F, Denys P, Joussain C. Safety and effectiveness of repeated botulinum toxin A intracavernosal injections in men with erectile dysfunction unresponsive to approved pharmacological treatments: real-world observational data. Toxins. 2023;15:382.","DOI":"10.3390\/toxins15060382"},{"key":"1042_CR103","doi-asserted-by":"crossref","unstructured":"Giuliano F, Denys P, Joussain C. Effectiveness and safety of intracavernosal incobotulinumtoxinA (Xeomin(\u00ae)) 100 U as an add-on therapy to standard pharmacological treatment for difficult-to-treat erectile dysfunction: a case series. Toxins. 2022;14:286.","DOI":"10.3390\/toxins14040286"},{"key":"1042_CR104","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.ijrobp.2010.04.017","volume":"80","author":"T Vuong","year":"2011","unstructured":"Vuong T, Waschke K, Niazi T, Richard C, Parent J, Liberman S, et al. The value of Botox-A in acute radiation proctitis: results from a phase I\/II study using a three-dimensional scoring system. Int J Radiat Oncol Biol Phys. 2011;80:1505\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1042_CR105","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00345-018-2193-y","volume":"36","author":"G Robert","year":"2018","unstructured":"Robert G, Descazeaud A, Karsenty G, Saussine C, Azzouzi AR, de la Taille A, et al. Prostatic injection of botulinum toxin is not inferior to optimized medical therapy in the management of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a randomized clinical trial. World J Urol. 2018;36:921\u20139.","journal-title":"World J Urol"},{"key":"1042_CR106","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jmb.2015.10.024","volume":"428","author":"S Sikorra","year":"2016","unstructured":"Sikorra S, Litschko C, M\u00fcller C, Thiel N, Galli T, Eichner T, et al. Identification and characterization of botulinum neurotoxin A substrate binding pockets and their re-engineering for human SNAP-23. J Mol Biol. 2016;428:372\u201384.","journal-title":"J Mol Biol"},{"key":"1042_CR107","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.toxicon.2015.09.025","volume":"107","author":"R Kaji","year":"2015","unstructured":"Kaji R. Clinical differences between A1 and A2 botulinum toxin subtypes. Toxicon. 2015;107:85\u20138.","journal-title":"Toxicon"},{"key":"1042_CR108","doi-asserted-by":"crossref","unstructured":"McNutt PM, Vazquez-Cintron EJ, Tenezaca L, Ondeck CA, Kelly KE, Mangkhalakhili M, et al. Neuronal delivery of antibodies has therapeutic effects in animal models of botulism. Sci Transl Med. 2021;13:eabd7789.","DOI":"10.1126\/scitranslmed.abd7789"},{"key":"1042_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144668","volume":"316","author":"N Mahheidari","year":"2025","unstructured":"Mahheidari N, Zamani S, Khademi R, Farahani MK, Molzemi S, Salehi M. Biological macromolecules Alginate-Carboxymethyl Cellulose (Alg-CMC) hydrogel loaded with Botulinum toxin type A for skin wound treatment and functional tissue regeneration. Int J Biol Macromol. 2025;316:144668.","journal-title":"Int J Biol Macromol"},{"key":"1042_CR110","doi-asserted-by":"crossref","unstructured":"Viravathana P, Tepp WH, Bradshaw M, Przedpelski A, Barbieri JT, Pellett S. Potency evaluations of recombinant botulinum neurotoxin A1 mutants designed to reduce toxicity. Int J Mol Sci. 2024;25:8955.","DOI":"10.3390\/ijms25168955"},{"key":"1042_CR111","doi-asserted-by":"publisher","first-page":"25069","DOI":"10.1021\/acsnano.4c06708","volume":"18","author":"D Wang","year":"2024","unstructured":"Wang D, Sun L, Shen WT, Haggard A, Yu Y, Zhang JA, et al. Neuronal membrane-derived nanodiscs for broad-spectrum neurotoxin detoxification. ACS Nano. 2024;18:25069\u201380.","journal-title":"ACS Nano"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01042-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:04:54Z","timestamp":1786701894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-025-01042-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1042"],"URL":"https:\/\/doi.org\/10.1038\/s41391-025-01042-y","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}